Showing results (1-10 of 857) with videos related to
Sort By:
Pageof 86
Cancers|December 23, 2023
Claudin18.2 in Advanced Gastric CancerRin Inamoto, Naoki Takahashi, Yasuhide YamadaWorld Journal of Gastroenterology|January 27, 2016
Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancerAkiko Kubo, Hironobu Hashimoto, Naoki Takahashi, et al.Cancer Medicine|July 6, 2026
Association of the PD-L1 CPS With the Efficacy of First-Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric CancerNozomu Ogura, Misa Ohnishi, Rin Inamoto, et al.International Journal of Cancer|July 15, 2018
A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinomaRoshni Roy, Raju Kandimalla, Fuminori Sonohara, et al.Archives of Medical Research|May 17, 2014
Combined assessment of epidermal [corrected] growth factor receptor dual color in situ hybridization and immunohistochemistry with downstream gene mutations in prediction of response to the anti-EGFR therapy for patients with metastatic colorectal cancerNaoki Takahashi, Yasuhide Yamada, Hirokazu Taniguchi, et al.Molecular Cancer|February 6, 2019
Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancerTakatoshi Matsuyama, Toshiaki Ishikawa, Naoki Takahashi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil]Yasuhide YamadaGlobal Health & Medicine|December 17, 2020
Present status and perspective of chemotherapy for patients with unresectable advanced or metastatic gastric cancer in JapanYasuhide YamadaGlobal Health & Medicine|March 16, 2022
Present status and perspective of perioperative chemotherapy for patients with resectable pancreatic cancer in JapanYasuhide YamadaPageof 86